BioCentury | Jan 5, 2018
Financial News

Autoimmune company Cue raises $66.2 million IPO

...of 8.8 million shares at $7.50 in an IPO underwritten by MDB Capital Group and Feltl...
BioCentury | Jan 2, 2018
Financial News

Cue spikes after pricing $66.2M IPO

...of 8.8 million shares at $7.50 in an IPO underwritten by MDB Capital Group and Feltl...
BioCentury | Dec 8, 2017
Financial News

Cancer company Cue Biopharma updates IPO plans

...to raise up to $40 million in an offering underwritten by MDB Capital Group and Feltl...
BioCentury | Nov 17, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...In September, Cue proposed a $40 million IPO on NASDAQ underwritten by MDB and Feltl...
BioCentury | Nov 16, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...In September, Cue proposed a $40 million IPO on NASDAQ underwritten by MDB and Feltl...
BioCentury | Sep 29, 2017
Financial News

Cue Biopharma proposes $40M IPO

...up to $40 million in an IPO on NASDAQ underwritten by MDB Capital Group and Feltl...
BioCentury | Sep 22, 2017
Financial News

Cue Biopharma proposes $40M IPO

...up to $40 million in an IPO on NASDAQ underwritten by MDB Capital Group and Feltl...
BioCentury | May 5, 2017
Financial News

BioLight withdraws follow-on

...to list its shares on NASDAQ in a U.S. IPO underwritten by H.C. Wainwright and Feltl...
BioCentury | Oct 17, 2016
Financial News

Biocept completes follow-on

...million Shares: 9.1 million Price: $1.10 Shares after offering: 17.5 million Underwriters: Roth Capital Partners; Feltl...
BioCentury | Oct 10, 2016
Financial News

Biocept amends follow-on

...be raised: Up to $11 million Shares: TBD Price prior: $0.58 Underwriters: Roth Capital Partners; Feltl...
...plans to raise up to $11 million. The company also added Roth Capital Partners and Feltl...
Items per page:
1 - 10 of 71
BioCentury | Jan 5, 2018
Financial News

Autoimmune company Cue raises $66.2 million IPO

...of 8.8 million shares at $7.50 in an IPO underwritten by MDB Capital Group and Feltl...
BioCentury | Jan 2, 2018
Financial News

Cue spikes after pricing $66.2M IPO

...of 8.8 million shares at $7.50 in an IPO underwritten by MDB Capital Group and Feltl...
BioCentury | Dec 8, 2017
Financial News

Cancer company Cue Biopharma updates IPO plans

...to raise up to $40 million in an offering underwritten by MDB Capital Group and Feltl...
BioCentury | Nov 17, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...In September, Cue proposed a $40 million IPO on NASDAQ underwritten by MDB and Feltl...
BioCentury | Nov 16, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...In September, Cue proposed a $40 million IPO on NASDAQ underwritten by MDB and Feltl...
BioCentury | Sep 29, 2017
Financial News

Cue Biopharma proposes $40M IPO

...up to $40 million in an IPO on NASDAQ underwritten by MDB Capital Group and Feltl...
BioCentury | Sep 22, 2017
Financial News

Cue Biopharma proposes $40M IPO

...up to $40 million in an IPO on NASDAQ underwritten by MDB Capital Group and Feltl...
BioCentury | May 5, 2017
Financial News

BioLight withdraws follow-on

...to list its shares on NASDAQ in a U.S. IPO underwritten by H.C. Wainwright and Feltl...
BioCentury | Oct 17, 2016
Financial News

Biocept completes follow-on

...million Shares: 9.1 million Price: $1.10 Shares after offering: 17.5 million Underwriters: Roth Capital Partners; Feltl...
BioCentury | Oct 10, 2016
Financial News

Biocept amends follow-on

...be raised: Up to $11 million Shares: TBD Price prior: $0.58 Underwriters: Roth Capital Partners; Feltl...
...plans to raise up to $11 million. The company also added Roth Capital Partners and Feltl...
Items per page:
1 - 10 of 71